Increased demand for non-invasive treatment procedures will drive the global aesthetic lasers and energy devices market

calendar_today 03 October, 2022 person_outline Growth Plus Reports

According to the deep-dive market assessment study by Growth+ Reports, the global aesthetic lasers and energy devices market was pegged at ~US$ 3.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of ~10% from 2022 to 2030.


The aesthetic lasers market is driven by rising disposable income, expanding technology, changing lifestyles, and increasing demand for minimally invasive aesthetic operations. Skin tightening treatments are utilized more commonly following rapid weight loss or bariatric surgery due to minimal invasiveness and product technology advancements. For instance, according to the CIA's The World Factbook 2020, Saint Pierre and Miquelon, Japan, Morocco, and Saint Pierre and Miquelon have the highest median ages. A population that is getting older is expected to adopt aesthetic procedures, which will probably encourage market expansion.


Different lasers, such as CO2, erbium, pulsed dye, and fractional, are adjusted for various skin problems and types in laser skin resurfacing. A CO2 laser is frequently used during laser skin resurfacing operations to remove damaged superficial skin from the entire face. For instance, the American Society of Plastic Surgeons (ASPS) released the 2020 findings of the organization's annual procedure survey in April 2021, coupled with national consumer research that represented developments over the COVID-19 period. According to the study, 35% of women who have had at least one cosmetic surgery or minimally invasive procedure plan to spend significantly more on treatments in 2021 than they did in 2020. With the increase of vaccines and the relaxation of social isolation laws, the processes are hoped to resume their regular path.


Studies have been published over the years to gain insight into the prevalence of diseases. For instance, according to the Global Burden of Disease Study, 117.4 million incident cases of acne vulgaris were recorded in 2019. According to the article "Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019," this reflects an increase of almost 48% from 1990.


Technology innovations and product launches are other drivers of market expansion. For instance, the LightSheer Quattro, the newest platform from Lumenis, was launched in January 2020. The device offers clinically validated laser hair removal treatments for all skin types utilizing either 805nm or 1060nm wavelengths with no downtime for pigmented and vascular lesions. However, the market for aesthetic lasers and energy devices is severely constrained by the high cost of these therapies. Furthermore, Aesthetic Lasers and Energy Devices are well recognized to have many adverse effects because these drugs react differently with various skin types and textures.


North America occupies the largest market share for aesthetic lasers and energy devices globally. It is projected to continue to hold this dominance throughout the forecast period.


This is due to rising healthcare costs and energy and cosmetic laser technology improvements. Europe is anticipated to grow steadily as the number of older adults increases. Moreover, Asia-Pacific is expected to have profitable growth. Due to the region's rising disposable income, larger untapped market, and swiftly increasing patient awareness. Also, the market's growth and expansion are due to growing medical tourism and an increase in minimally invasive aesthetic surgical procedures. This, along with an aging population on the rise and relatively affordable cosmetic procedures.


The market for energy and aesthetic lasers is highly competitive. Some of the prominent market players in the global aesthetic lasers and energy devices market include

  Mentor Corporation, Alma Lasers, Solta Medical, Inc., Lumenis Ltd., Palomar Medical Technologies, Cynosure Inc., Photomedex Inc., Candela Medical, Syneron Medical, Ltd., Medicis Pharmaceuticals Corporation, Zeltiq Aesthetics, Lutronic, Inc, Chromognex Technologies Ltd., Cutera Palomar Medical Technologies, Ultrashape Ltd., Allergan, Inc., Sciton, Inc. and IRIDEX Corp. To maintain and expand their market share globally, different players are using competitive strategies such as partnerships, acquisitions, and capitalizing on unexplored potential in India and China's developing economies. For instance, Accure Acne, Inc. was granted the European CE certification in May 2020 for its ground-breaking Accure Laser system to treat patients with moderate acne vulgaris. The Accure Laser is the only light-based system created for a market that can directly target and damage sebaceous glands, the primary source of sebum production and the key to effective long-term acne therapy.

awards awards key differentiators

Reach Us

enquire@growthplusreports.com

Web –  www.growthplusreports.com

// // // //